Skip to main content

Advertisement

SpringerLink
Log in

Lipid profile in Tunisian patients with rheumatoid arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aims to assess the prevalence of dyslipidaemia in Tunisian patients with active RA and to investigate the clinical and biological associated factors. A cross-sectional study was conducted on 92 unselected patients with active RA (77 females and 15 males, aged 49.1 ± 12.5 years) and 82 healthy subjects (68 females and 14 males, aged 50.8 ± 13.3 years). We recorded the patients' characteristics and the results of a lipid profile test (total cholesterol, TC; high-density lipoprotein cholesterol, HDL-c; low-density lipoprotein cholesterol, LDL-c; triglyceride, TG; lipoprotein (a), Lp (a); apolipoprotein A-1, apo A-1 and apolipoprotein B, apo B). In comparison to the control group, RA patients showed a higher prevalence of associated dyslipidaemia (95.7% versus 65.9% of cases, p < 0.001). Sera of patients showed higher TC (4.86 ± 1.07 versus 3.98 ± 0.73 mmol/L, p < 0.001), LDL-c (3.49 ± 0.98 versus 1.99 ± 0.62 mmol/L, p < 0.001), Lp (a) (288.04 ± 254.59 versus 187.94 ± 181.37 mmol/L, p = 0.004) and lower HDL-c (0.66 ± 0.24 versus 1.12 ± 0.3 mmol/L, p < 0.001). TC/HDL-c, LDL-c/HDL-c and non-HDL-c/HDL-c were also higher in RA patients; they were 8.24 ± 3.20 versus 3.76 ± 1.26 (p < 0.001), 5.91 ± 2.48 versus 1.92 ± 0.99 (p < 0.001) and 7.24 ± 3.20 versus 2.76 ± 1.26 (p < 0.001), respectively. Apo A-1 was correlated to Lp (a) (r = 0.291, p = 0.005). Corticoid dose was not associated to dyslipidaemia, but in multiple regression models, corticoid dose may be negatively related to some atherogenic markers, in particular non-HDL-c. Tunisian patients with markedly active RA experience substantially reduced serum HDL-c and increased TC, LDL-c and Lp (a) concentrations as well as increased TC/HDL-c, LDL-c/HDL-c and non-HDL-c/HDL-c ratios.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Soubrier M, Dougados M (2006) Athérome et polyarthrite rhumatoïde. Rev Med Int 27:125–136

    Article  CAS  Google Scholar 

  2. Nurmohamed MT (2007) Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag 3:845–852

    PubMed  CAS  Google Scholar 

  3. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756–763

    Article  PubMed  CAS  Google Scholar 

  4. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N et al (2005) Accelerated atherosclerosis in autoimmune rheumatic disease. Circulation 112:3337–3347

    Article  PubMed  Google Scholar 

  5. Ku IA, Imboden JB, Hsue PY, Ganz P (2009) Rheumatoid arthritis a model of systemic inflammation driving atherosclerosis. Circ J 73:977–985

    Article  PubMed  CAS  Google Scholar 

  6. Assous N, Touzé E, Meune C, Kahan A, Allanore Y (2007) Morbimortlité cardiovasculaire au cours de la polyarthrite rhumatoïde: étude de cohorte hospitalière monocentrique française. Rev Rhum 74:72–78

    Article  Google Scholar 

  7. García-Gómez C, Nolla JM, Valverde J, Gómez-Gerique JA, Castro MJ, Pintó X (2009) Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis. J Rheumatol 36:1365–1370

    Article  PubMed  Google Scholar 

  8. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 256:2835–2838

    Article  PubMed  CAS  Google Scholar 

  9. Walldius G, Jungner I (2006) The apo B/apo A-1 ratio: a strong, new risk factor for cardiovascular disease and a target for lipid – lowering therapy a review of the evidence. J Intern Med 259:493–519

    Article  PubMed  CAS  Google Scholar 

  10. Blaha MJ, Blumenthal RS, Brinton EA, Jacobson TA, National Lipid Association Taskforce on Non-HDL Cholesterol (2008) The importance of non-HDL cholesterol reporting in lipid management. J Clin Lipidol 2:267–73

    Article  PubMed  Google Scholar 

  11. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with ant without rheumatoid arthritis. Arthritis Rheum 50:3444–3449

    Article  PubMed  Google Scholar 

  12. Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE et al (2003) Influence of glucocorticoïd and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842–845

    Article  PubMed  CAS  Google Scholar 

  13. Park YB, Hk C, Kim MY, Lee WK, Song J, Kim DK et al (2002) Effect of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis a prospective study. Am J Med 113:188–193

    Article  PubMed  CAS  Google Scholar 

  14. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH et al (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701–1704

    PubMed  CAS  Google Scholar 

  15. Van Halm VP, Nielen MMJ, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE et al (2007) Lipids and inflammation: serial measurement of the lipid profile of blood donors who later develop RA. Ann Rheum Dis 66:184–188

    Article  PubMed  Google Scholar 

  16. Dursunoglu D, Evrengül H, Polat B, Tanriverdi H, Cobankara V, Kaftan A et al (2005) Lp (a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relation ship to inflammation. Rheumatol Int 25:241–245

    Article  PubMed  CAS  Google Scholar 

  17. Lee YH, Choi SJ, Ji JD, Seo HS, Song GG (2000) Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 19:324–325

    Article  PubMed  CAS  Google Scholar 

  18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  19. Fransen J, van Riel PL (2005) The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 23:S93–S99

    PubMed  CAS  Google Scholar 

  20. Steinbroker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662

    Google Scholar 

  21. Dessein PH, Christian BF, Solomon A (2009) Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context? J Rheumatol 36:1357–1361

    Article  PubMed  Google Scholar 

  22. Burger D, Dayer JM (2002) High-density lipoprotein-associated apolipoprotein A-1: the missing link between infection and chronic inflammation? Autoimmun Rev 1:111–117

    Article  PubMed  CAS  Google Scholar 

  23. Sfar S, Laporte F, Braham H, Jawed A, Amor S, Kerkeni A (2010) Influence of dietary habits, age and gender on plasma fatty acids levels in a population of healthy Tunisian subjects. Exp Gerontol. doi:10.1016/j.exerg.2010.05.003

    PubMed  Google Scholar 

  24. Navarro-Cano G, Del Rincon I, Pogosian S, Roldan JF, Escalante A (2003) Association of mortality with disease severity in rheumatoïd arthritis, independent of comorbidity. Arthritis Rheum 48:2425–2433

    Article  PubMed  Google Scholar 

  25. Wolfe F, Michaud K, Gefeller O, Choi HK (2003) Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 48:1530–1542

    Article  PubMed  Google Scholar 

  26. Dessein PH, Joffe BI (2006) When is a patient with rheumatoid arthritis at risk for cardiovascular disease? J Rheumatol 33:201–203

    PubMed  Google Scholar 

  27. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  28. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK 3rd, Roux-Lombard P et al (2001) Apolipoprotein A-1 inhibits the production of IL1-β and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381–2389

    Article  PubMed  CAS  Google Scholar 

  29. Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121:S21–S31

    Article  PubMed  CAS  Google Scholar 

  30. Mak A, Ho RC-M, Tan JY-S, Teng GG, Lahiri M, Lateef A et al (2009) Atherogenic serum lipid profile is an independant predictor for gouty flares in patients with gouty arhropathy. Rheumatology 48:262–265

    Article  PubMed  CAS  Google Scholar 

  31. Hulthe J, Fagerberg B (2002) Circulated oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Aterioscler Thromb Vasc Biol 22:1162–1167

    Article  CAS  Google Scholar 

  32. Fraser DA, Thoen J, Rustan AC, Forre O, Kjeldsen-Kragh (1999) Changes in plasma free fatty acid concentrations in rheumatoid arthritis patients during fasting and their effects upon T-lymphocyte proliferation. Rheumatology 38:948–952

    Article  PubMed  CAS  Google Scholar 

  33. Hafstrom I, Rohani M, Denerberg S, Wornert M, Jogestrand T, Frostegard J (2007) Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis. A randomized study. J Rheumatol 34:1810–1816

    PubMed  Google Scholar 

  34. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodringuez T, Martin J, Llorca J (2008) Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease. Arthritis Res Ther 10:403

    Article  PubMed  Google Scholar 

  35. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-diaz E, Testa A, Garcia-Porrua C et al (2007) Endothelial dysfonction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:287–293

    Article  PubMed  CAS  Google Scholar 

  36. Veldhuyzen Van Zanter JJCS, Kites GD (2008) Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 10:102–103

    Article  Google Scholar 

  37. Svenson KL, Lithell H, Hallgren R, Vessby B (1987) Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides II. Effects of anti-inflammatory and disease modifying drug treatment. Arch Intern Med 147:1917–1920

    Article  PubMed  CAS  Google Scholar 

  38. Kremers HM, Reinalda MS, Crowson CS, Davis JM, Hunder GG, Gabriel SE (2007) Glucocorticoïds and cardiovascular and cerebrovascular events in polymyalgie rheumatica. Arthritis Rheum 57:279–286

    Article  CAS  Google Scholar 

  39. Peters MJL, Symmons DPM, McCarey D, Dijkmans BAC, Nicola P, Kvien TK et al (2010) Recommendations EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331

    Article  PubMed  CAS  Google Scholar 

  40. McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I et al (2004) Trial of atrovastatin in rheumatoid arthritis (TARA): double –blind, randomised placebo-controlled trial. Lancet 363:2015–2021

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Rheumatology Department, Monastir Teaching Hospital, avenue 1er Juin, 5000, Monastir, Tunisia

    Saoussen Hassen Zrour, Mahbouba Jguirim, Wided Korbaa, Mohamed Younes, Ismail Bejia, Mongi Touzi & Naceur Bergaoui

  2. Biochemistry Department, Monastir Teaching Hospital, 5000, Monastir, Tunisia

    Fadoua Hassine Neffeti & Najjar Mohamed Fadel

  3. Immunology Department, Monastir Teaching Hospital, 5000, Monastir, Tunisia

    Nabil Sakly

Authors
  1. Saoussen Hassen Zrour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fadoua Hassine Neffeti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nabil Sakly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahbouba Jguirim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wided Korbaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohamed Younes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ismail Bejia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mongi Touzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Najjar Mohamed Fadel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Naceur Bergaoui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saoussen Hassen Zrour.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassen Zrour, S., Hassine Neffeti, F., Sakly, N. et al. Lipid profile in Tunisian patients with rheumatoid arthritis. Clin Rheumatol 30, 1325–1331 (2011). https://doi.org/10.1007/s10067-011-1755-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1755-9

Keywords

Search

Navigation